Amplitude Vascular Systems a Boston, MA-based medical device company, raised $36M in Series B Funding.
Backers were not disclosed.
The company intends to use the funds to support the U.S. peripheral commercial launch as well as U.S. coronary and carotid IDE trials for its Pulse Intravascular Lithotripsy™ (PIVL™) device.
AVS is a medical device company focused on safely and effectively treating severely calcified arterial disease. The Pulse Intravascular Lithotripsy™ (PIVL™) System is an investigational device and not yet cleared for commercial distribution within or outside the United States.
AVS is backed by global investors including BioStar Capital, Cue Growth Partners, and others.
